BioCentury
ARTICLE | Company News

Biolucidation LLC, Melior deal

July 15, 2013 7:00 AM UTC

Melior acquired all assets of CRO Biolucidation, which specialized in drug abuse liability studies. Melior said the acquisition significantly expands its preclinical pharmacology capabilities. Melior ...